EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.473
https://www.valueinhealthjournal.com/article/S1098-3015(24)00588-6/fulltext
Title :
EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00588-6&doi=10.1016/j.jval.2024.03.473
First page :
Section Title :
Open access? :
No
Section Order :
11812